VANGUARD GROUP INC 13D and 13G filings for Cara Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 5:01 pm Sale |
2023-12-29 | 13G | Cara Therapeutics, Inc. CARA |
VANGUARD GROUP INC | 219,256 4.830% |
-39,221 (-15.17%) |
Filing |
| 2023-02-09 11:12 am Purchase |
2022-12-30 | 13G | Cara Therapeutics, Inc. CARA |
VANGUARD GROUP INC | 258,477 5.770% |
5,747 (+2.27%) |
Filing |
| 2022-02-09 3:33 pm Purchase |
2021-12-31 | 13G | Cara Therapeutics, Inc. CARA |
VANGUARD GROUP INC | 252,730 5.670% |
252,730 (New Position) |
Filing |